DUREZOL

This brand name is authorized in Canada, Ecuador, United States

Active ingredients

The drug DUREZOL contains one active pharmaceutical ingredient (API):

1 Difluprednate UNII S8A06QG2QE - DIFLUPREDNATE

Difluprednate is a topical corticosteroid indicated for the treatment of inflammation and pain associated with ocular surgery. Corticosteroids inhibit the inflammatory response to a variety of inciting agents and may delay or slow healing. There is no generally accepted explanation for the mechanism of action of ocular corticosteroids. Read about Difluprednate

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
DUREZOL Emulsion	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D07AC19	Difluprednate	D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07A Corticosteroids, plain → D07AC Corticosteroids, potent (group III)
Discover more medicines within D07AC19

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02415534
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 648-MEE-0115
Country: US	FDA, National Drug Code	Identifier(s): 0065-9240